Irreversible Electroporation in Patients with Pancreatic Cancer: How Important Is the New Weapon?

Figure 3

Forest plot of the pooled prevalence data of complete response at 2 months (a), partial response at 3 months (b), and progression at 3 months (c) among studies targeting the effect of IRE therapy in patients with PC.

(a)

(b)

(c)